
|Videos|August 24, 2021
42-Year-Old Female With Itchy Eyes
This program is sponsored by Eyevance Pharmaceuticals, a Santen company.
Advertisement
Mark S. Milner, MD
Board-certified Ophthalmologist
Associate Clinical Professor, Yale University School of Medicine,
New Haven, Connecticut
Director of Cornea, Goldman Eye, Palm Beach Gardens, Florida
Co-Chief Medical Officer, Eyevance Pharmaceuticals, a Santen company
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
AAO 2025: Philip J. Ferrone, MD, highlights safety and efficacy findings of gildeuretinol in Stargardt disease
2
Preclinical study suggests synaptic regeneration may offer new pathway to treat glaucoma
3
AAO 2025: The evolution of eye care on display at AAO 2025
4
Ocular pickleball injuries rise sharply with increasing game popularity
5